These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23365058)

  • 1. Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy.
    Lassche S; Stienen GJ; Irving TC; van der Maarel SM; Voermans NC; Padberg GW; Granzier H; van Engelen BG; Ottenheijm CA
    Neurology; 2013 Feb; 80(8):733-7. PubMed ID: 23365058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved single muscle fiber specific force in facioscapulohumeral muscular dystrophy.
    Lassche S; Voermans NC; van der Pijl R; van den Berg M; Heerschap A; van Hees H; Kusters B; van der Maarel SM; Ottenheijm CAC; van Engelen BGM
    Neurology; 2020 Mar; 94(11):e1157-e1170. PubMed ID: 31964688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol.
    Lassche S; Ottenheijm CA; Voermans NC; Westeneng HJ; Janssen BH; van der Maarel SM; Hopman MT; Padberg GW; Stienen GJ; van Engelen BG
    BMC Neurol; 2013 Oct; 13():144. PubMed ID: 24119284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facioscapulohumeral dystrophy weakened sarcomeric contractility is mimicked in induced pluripotent stem cells-derived innervated muscle fibres.
    Laberthonnière C; Novoa-Del-Toro EM; Delourme M; Chevalier R; Broucqsault N; Mazaleyrat K; Streichenberger N; Manel V; Bernard R; Salort Campana E; Attarian S; Nguyen K; Robin JD; Baudot A; Magdinier F
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):621-635. PubMed ID: 34859613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy.
    Lassche S; Voermans NC; Schreuder T; Heerschap A; Küsters B; Ottenheijm CA; Hopman MT; van Engelen BG
    Muscle Nerve; 2021 Jan; 63(1):60-67. PubMed ID: 32959362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titin-based stiffening of muscle fibers in Ehlers-Danlos Syndrome.
    Ottenheijm CA; Voermans NC; Hudson BD; Irving T; Stienen GJ; van Engelen BG; Granzier H
    J Appl Physiol (1985); 2012 Apr; 112(7):1157-65. PubMed ID: 22223454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.
    Hanel ML; Sun CY; Jones TI; Long SW; Zanotti S; Milner D; Jones PL
    Differentiation; 2011 Feb; 81(2):107-18. PubMed ID: 20970242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional sarcomere contractility contributes to muscle weakness in ACTA1-related nemaline myopathy (NEM3).
    Joureau B; de Winter JM; Conijn S; Bogaards SJP; Kovacevic I; Kalganov A; Persson M; Lindqvist J; Stienen GJM; Irving TC; Ma W; Yuen M; Clarke NF; Rassier DE; Malfatti E; Romero NB; Beggs AH; Ottenheijm CAC
    Ann Neurol; 2018 Feb; 83(2):269-282. PubMed ID: 29328520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy.
    Reed P; Porter NC; Strong J; Pumplin DW; Corse AM; Luther PW; Flanigan KM; Bloch RJ
    Ann Neurol; 2006 Feb; 59(2):289-97. PubMed ID: 16437580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
    Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
    Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound Imaging of Muscle Contraction of the Tibialis Anterior in Patients with Facioscapulohumeral Dystrophy.
    Gijsbertse K; Goselink R; Lassche S; Nillesen M; Sprengers A; Verdonschot N; van Alfen N; de Korte C
    Ultrasound Med Biol; 2017 Nov; 43(11):2537-2545. PubMed ID: 28764967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
    Banerji CRS; Henderson D; Tawil RN; Zammit PS
    Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype may predict the clinical course of facioscapolohumeral muscular dystrophy.
    Ricci G; Cammish P; Siciliano G; Tupler R; Lochmuller H; Evangelista T
    Muscle Nerve; 2019 Jun; 59(6):711-713. PubMed ID: 30895627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction.
    Manders E; de Man FS; Handoko ML; Westerhof N; van Hees HW; Stienen GJ; Vonk-Noordegraaf A; Ottenheijm CA
    Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(12):L1070-8. PubMed ID: 22962018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle strength, quantity and quality and muscle fat quantity and their association with oxidative stress in patients with facioscapulohumeral muscular dystrophy: Effect of antioxidant supplementation.
    Wilson VD; Bommart S; Passerieux E; Thomas C; Pincemail J; Picot MC; Mercier J; Portet F; Arbogast S; Laoudj-Chenivesse D
    Free Radic Biol Med; 2024 Jul; 219():112-126. PubMed ID: 38574978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of weakness of orofacial muscles on swallowing and communication in FSHD.
    Mul K; Berggren KN; Sills MY; McCalley A; van Engelen BGM; Johnson NE; Statland JM
    Neurology; 2019 Feb; 92(9):e957-e963. PubMed ID: 30804066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score.
    Lamperti C; Fabbri G; Vercelli L; D'Amico R; Frusciante R; Bonifazi E; Fiorillo C; Borsato C; Cao M; Servida M; Greco F; Di Leo R; Volpi L; Manzoli C; Cudia P; Pastorello E; Ricciardi L; Siciliano G; Galluzzi G; Rodolico C; Santoro L; Tomelleri G; Angelini C; Ricci E; Palmucci L; Moggio M; Tupler R
    Muscle Nerve; 2010 Aug; 42(2):213-7. PubMed ID: 20544930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prosthetic treatment of a patient with facioscapulohumeral muscular dystrophy: a clinical report.
    Güler AU; Ceylan G; Ozkoç O; Aydiin M; Cengiz N
    J Prosthet Dent; 2003 Oct; 90(4):321-4. PubMed ID: 14564285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction.
    Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D
    Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.